Mandaviya to launch National Policy on Research and Development and Innovation in Pharma-MedTech Sector

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Medlarge Pharma News, Latest, Top News

Dr. Mansukh Mandaviya, Union Minister of Chemicals and Fertilisers and Minister of Health
& Family Welfare, Government of India will launch the National Policy on Research and
Development and Innovation in Pharma-MedTech Sector in India and Scheme for promotion
of Research and Innovation in Pharma MedTech Sector (PRIP) in the presence of Shri
Bhagwanth Khuba, Union Minister of State for Chemicals and Fertilisers and Renewable
Energy and Dr V.K. Paul, Member, NITI Aayog. The event will be organised by Department
of Pharmaceuticals tomorrow at India International Centre.

The National Policy on Research and Development in the Pharma-MedTech Sector in India
can potentially help in growing the sector to USD 120-130 Billion over the next decade,
increasing its contribution to the GDP by about 100 basis points. The policy aims to
encourage R&D in pharmaceuticals, including traditional medicines & phytopharmaceuticals and medical devices. The policy acknowledged the need for greater
emphasis on encouraging R&D, through indigenously developed cutting-edge products and
technologies upon three focus areas, namely, strengthening the regulatory framework,
incentivising investments in innovation and creating a facilitatory ecosystem for Innovation.

The event will see active participation from other dignitaries, including policymakers, experts
from the healthcare sector along with representative from academia, think tanks, industry and
media. This gathering aims to highlight the India’s drug and pharmaceutical export trend,
India’s category wise export share, the preamble, need for the policy, its objectives, focus
areas of the objectives and monitoring and evaluation mechanism.